People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids, new treatment ...

A new study by Phoenix's Barrow Neurological Institute and the University of Calgary has found which injectable treatments ...

Lidocaine injections into the greater occipital nerve relieve severe, refractory migraine attacks in children, results of a randomized controlled trial show. Investigators found children receiving ...

A University of Calgary professor and neurologist, Dr. Serena Orr, helped develop the new American Headache Society ...

Calgary researchers recommend optical nerve blockers for the management of migraine attacks in emergency departments.

Please provide your email address to receive an email when new articles are posted on . The study included 58 young persons with migraine flares lasting 24 hours to 3 months. A majority of those given ...

A new study by Phoenix’s Barrow Neurological Institute is leading to changes in how migraine patients are treated in ...

A new study by Phoenix’s Barrow Neurological Institute and the University of Calgary has found which injectable treatments showed the most benefit for migraine patients and should be routinely offered ...

A noninvasive, self-administered neurostimulation device recently approved by the US Food and Drug Administration (FDA) is safe, tolerable, and offers "highly effective" pain relief in acute migraine, ...

Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...

Migraine impacts millions worldwide, causing severe pain, nausea, and sensitivity to light and sound. While prescription medications may help, they aren’t the only option. There are some innovative ...